U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions ; day:27 ; month:2 ; year:2018 ; pages:1-4
Leukemia ; (27.2.2018), 1-4
- Creator
-
Tefferi, Ayalew
- Contributor
-
Finke, Christy M.
Lasho, Terra L.
Hanson, Curtis A.
Ketterling, Rhett P.
Gangat, Naseema
Pardanani, Animesh
SpringerLink (Online service)
- DOI
-
10.1038/s41375-018-0078-0
- URN
-
urn:nbn:de:1111-2018051614352
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tefferi, Ayalew
- Finke, Christy M.
- Lasho, Terra L.
- Hanson, Curtis A.
- Ketterling, Rhett P.
- Gangat, Naseema
- Pardanani, Animesh
- SpringerLink (Online service)
Other Objects (12)
Myelofibrosis
Party distinctions
False Distinctions
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea
2. Distinctions préalables
Mutation profile in Indian primary myelofibrosis patients and its clinical implications
Distinctions: the circle game
Chapitre III – Distinctions préliminaires
Time distinctions in Kaingáng
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
A couple of neglected distinctions
Myelofibrosis
Party distinctions
False Distinctions
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea
2. Distinctions préalables
Mutation profile in Indian primary myelofibrosis patients and its clinical implications
Distinctions: the circle game
Chapitre III – Distinctions préliminaires
Time distinctions in Kaingáng
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
A couple of neglected distinctions
Myelofibrosis
Party distinctions
False Distinctions
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea
2. Distinctions préalables
Mutation profile in Indian primary myelofibrosis patients and its clinical implications
Distinctions: the circle game
Chapitre III – Distinctions préliminaires
Time distinctions in Kaingáng
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis